A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy ...

During the dog days of summer, columnist Sam Kirton takes special care to protect himself from medication side effects.

A Phase 2 clinical trial has begun recruiting that’s assessing the safety and efficacy of LTI-03, Rein Therapeutics’ inhaled therapy for idiopathic pulmonary fibrosis (IPF). RENEW (NCT06968845) is ...

GRI Bio has reached an interim enrollment goal for its Phase 2a clinical trial testing GRI-0621 — a therapy targeting natural killer T-cells (NKT cells) to treat idiopathic pulmonary fibrosis (IPF) — ...

Fibrotic diseases are ones, like pulmonary fibrosis, in which scar tissue — medically known as fibrosis — thickens and hardens, often building up in the body.In IPF, a progressive lung disease, such ...

In people with IPF, however, senescence markers are more abundant than in healthy individuals, and the abnormal persistence of these cells has been linked to inflammation and scar tissue formation..

“What we found most striking in this study is that all the fibrotic regions of IPF patients’ lungs are covered by antibody-producing plasma cells,” Qi Yang, MD, PhD, associate professor at the Rutgers ...

When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in 2017, I searched for more knowledge about my disease. I found a reliable source in the Pulmonary Fibrosis Foundation.The information on ...

Although there is no cure for IPF, two antifibrotic medications have been approved to treat the condition: Esbriet (pirfenidone) and Ofev (nintedanib), both of which can slow lung function decline.